Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2020-08-19 | 2021-01-11 | 122480 |
| APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2020-04-13 | 2020-05-04 | 111918 |
| APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2018-07-11 | 2018-08-09 | 55276 |
| APO-FAMCICLOVIR | 500MG | TABLET | Resolved | 2020-04-15 | 2020-05-04 | 112189 |
| APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2023-01-06 | 2023-02-09 | 180116 |
| APO-FAMCICLOVIR | 500MG | TABLET | Resolved | 2019-05-22 | 2019-09-06 | 84535 |
| APO-FAMCICLOVIR | 500MG | TABLET | Resolved | 2017-07-26 | 2018-01-18 | 17234 |
| APO-FAMCICLOVIR | 500MG | TABLET | Resolved | 2019-01-15 | 2019-04-26 | 72354 |
| APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2022-07-15 | 2022-09-23 | 164701 |
| APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2024-10-10 | 2024-12-20 | 239813 |
| APO-FAMCICLOVIR | 125MG | TABLET | Resolved | 2020-10-07 | 2020-12-29 | 125803 |
| APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2018-09-04 | 2018-12-18 | 59816 |
| APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2020-02-05 | 2020-02-25 | 105333 |
| APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2019-03-13 | 2019-08-31 | 78497 |
| APO-FAMCICLOVIR | 125MG | TABLET | Resolved | 2021-11-23 | 2021-12-09 | 149730 |
| APO-FAMCICLOVIR | 125MG | TABLET | Resolved | 2022-04-08 | 2022-05-13 | 158353 |
| APO-FAMOTIDINE | 10MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19048 |
| APO-FAMOTIDINE TAB 20MG USP | 20 MG | TABLET | Resolved | 2017-03-11 | 2018-09-09 | 619 |
| APO-FAMOTIDINE TAB 40MG USP | 40MG | TABLET | Resolved | 2017-03-11 | 2018-09-09 | 616 |
| APO-FELODIPINE | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-07-11 | 2018-08-01 | 55299 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |